Treatment of glaucoma in patients with dry eye syndrome

被引：4
作者：
Labbe, A. [1 ,2 ,3 ,4 ]
Baudouin, C. [1 ,2 ,3 ,4 ]
机构：
[1] CHNO Quinze Vingts, Serv Ophtalmol 3, F-75012 Paris, France
[2] Univ Paris 06, INSERM, Inst Vis, UMRS 968, Paris, France
[3] Hop Ambroise Pare, AP HP, Serv Ophtalmol, Boulogne, France
[4] Univ Versailles, Versailles, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2010年 / 33卷 / 04期
关键词：
Glaucoma; Ocular hypertension; Treatment; Dry eye; SELECTIVE LASER TRABECULOPLASTY; TOPICAL ANTIGLAUCOMA MEDICATION; OCULAR SYMPTOMS; PREVALENCE; EYEDROPS; SIGNS;
D O I：
10.1016/j.jfo.2010.02.006
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
The treatments of glaucoma or ocular hypertension are associated with numerous ocular surface changes. Similarly, these ocular surface modifications directly impact the effectiveness of these therapies. The management of patients with glaucoma or ocular hypertension also suffering from dry eye syndrome needs to reduce eye drop-induced toxicity as well as a specific treatment for the ocular surface. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：285 / 290
页数：6
相关论文
共 31 条
  • [11] Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids
    Dursun, D
    Kim, MC
    Solomon, A
    Pflugfelder, SC
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (01) : 8 - 13
  • [12] Pharmacological management of dry eye in the elderly patient
    Foulks, Gary N.
    [J]. DRUGS & AGING, 2008, 25 (02) : 105 - 118
  • [13] CYTOTOXICITY OF OPHTHALMIC PRESERVATIVES
    GASSET, AR
    ISHII, Y
    KAUFMAN, HE
    MILLER, T
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1974, 78 (01) : 98 - 105
  • [14] Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial
    Hodge, WG
    Damji, KF
    Rock, W
    Buhrmann, R
    Bovell, AM
    Pan, Y
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (09) : 1157 - 1160
  • [15] Ocular symptoms and signs with preserved and preservative-free glaucoma medications
    Jaenen, N.
    Baudouin, C.
    Pouliquen, P.
    Manni, G.
    Figueiredo, A.
    Zeyen, T.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (03) : 341 - 349
  • [16] Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma
    Juzych, MS
    Chopra, V
    Banitt, MR
    Hughes, BA
    Kim, C
    Goulas, MT
    Shin, DH
    [J]. OPHTHALMOLOGY, 2004, 111 (10) : 1853 - 1859
  • [17] Wound healing modulation in glaucoma surgery
    Labbe, A.
    Khammari, C.
    Baudouin, C.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2007, 30 (06): : 631 - 646
  • [18] Lachkar Y, 2008, J FR OPHTALMOL, V31, P85
  • [19] Five-year follow up of selective laser trabeculoplasty in Chinese eyes
    Lai, JS
    Chua, JKH
    Tham, CCY
    Lam, DSC
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 32 (04) : 368 - 372
  • [20] Prevalence of ocular surface disease in glaucoma patients
    Leung, Eamon W.
    Medeiros, Felipe A.
    Weinreb, Robert N.
    [J]. JOURNAL OF GLAUCOMA, 2008, 17 (05) : 350 - 355
1234